DUBLIN--(BUSINESS WIRE)--The "Global Cataract Surgery Devices Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
Cataract Surgery Devices Market was valued at $7 billion in 2016, and is estimated to reach $9 billion by 2023, growing at a CAGR of 4.3% during the forecast period.
Increase in incidences of diseases such as diabetes, obesity, hypertension and growth in geriatric population contributes to the growth of the market.
Lack of skilled professionals is a major cause that is expected to limit the market growth during the forecast period.
Considering the case, the governments and non-profit organizations around the world are introducing programs to reduce the burden of cataract-related diseases, which is expected to offer tremendous opportunities for key market players.
Based on type, the market is segmented into Equipment and Consumables.
Based on product, the market is segmented into Intraocular Lens (IOL), Ophthalmic Viscoelastic Device (OVD), and Phacoemulsification Equipment.
The end user covered under the report are Hospitals, Ophthalmology Clinics, and Ambulatory Surgery Centers.
The geographies included in the report are North America, Europe, Asia-Pacific, Middle East and Africa. For better analysis, the geographies are segmented into countries.
Key Topics Covered
1. Market Scope & Methodology
1.1 Market Definition
1.3 Market Scope
1.5 Methodology for the research
2. Market Overview
2.2 Drivers, Restraints and Opportunities
3. Global Cataract Surgery Devices Market
3.1 Global Cataract Surgery Devices Market by Type
4. Global Cataract Surgery Devices Market by Product
5. Global Cataract Surgery Devices Market by End User
6. Global Cataract Surgery Devices Market by Region
6.1 North America Cataract Surgery Devices Market
6.2 Europe Cataract Surgery Devices Market
6.3 Asia-Pacific Cataract Surgery Devices Market
6.4 LAMEA Cataract Surgery Devices Market
7. Company Profiles
7.1 Essilor International S.A.
7.2 Carl Zeiss AG
7.4 Topcon Corporation (Topcon Positioning Systems, Inc.)
7.6 Novartis AG
7.7 Johnsons & Johnsons
7.8 Ziemer Ophthalmic Systems AG
7.9 Nidek Co., Ltd
7.10 Valeant Pharmaceuticals International, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/ldjdfx/cataract_surgery?w=4